Get 50% OFF This Monsoon!
GKB Ophthalmics
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Incorporated in Dec.'81 as a public limited company, GKB Opthalmics was granted a licence as a 100% EOU in 1982. The company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Ltd and The Maharashtra State Financial Corporation. It was promoted by K G Gupta, K M Gupta, B K Gupta and Ravi Gupta.
The company is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses. Commercial production commenced in May '83. It has an installed capacity of 30 lac lenses pa. The company completed the expansion programme by expanding the capacity of single vision lenses to 33 lac pcs pa. It also installed facilities for coating 1.72 lac pcs of lenses pa. The above project was completed at a new loacation -- Pilerne Industrial Estate, Bardez-Goa. The company has shifted the single vision plant to the new premises in phases. In 1996-97, it increased the installed capacity of ophthamal lenses by 9,00,000 nos to 30,00,000 nos.
The company had floated a wholly owned subsidiary (WOS) at Bermen, Germany which acts as a stock point and have proper liasion with the buyers in and around Europe. To utilise its full capacity the company is planning to take a new shed which is adjacent to the current factory area, and the total area of the new shed is 1656 sq.mtrs. The associate company viz GKB Vision is performing well and has reported a healthy turnover. GKB ophthalmics ltd has made a substantial investment in the associated company.
GKB Ophthalmics share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of GKB Ophthalmics indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how GKB Ophthalmics is valued compared to its competitors.
GKB Ophthalmics PE ratio helps investors understand what is the market value of each stock compared to GKB Ophthalmics 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of GKB Ophthalmics evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively GKB Ophthalmics generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of GKB Ophthalmics in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of GKB Ophthalmics shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of GKB Ophthalmics compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of GKB Ophthalmics over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of GKB Ophthalmics helps investors get an insight into when they can enter or exit the stock. Key components of GKB Ophthalmics Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where GKB Ophthalmics shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect GKB Ophthalmics ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of GKB Ophthalmics provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of GKB Ophthalmics highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of GKB Ophthalmics .
The balance sheet presents a snapshot of GKB Ophthalmics ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.